NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00388726,E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer,https://clinicaltrials.gov/study/NCT00388726,,COMPLETED,"The purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated with E7389 versus the Treatment of Physician's Choice (TPC) in patients with locally recurrent or metastatic breast cancer.",YES,Breast Cancer,DRUG: E7389|DRUG: Physician's Choice,"Overall Survival, Defined as the time from the date of randomization until the date of death from any cause., From date of randomization until death from any cause","Progression-Free Survival., Measured using Response Evaluation Criteria in Solid Tumors (RECIST) and defined as the time from the date of randomization until progressive disease or death from any cause in the absence of of progressive disease., Until disease progression or death.|Best Overall Response, Measured by RECIST criteria and defined as the best response from the start of treatment until disease progression or recurrence. Lesions measured by computed tomography (CT) scan and magnetic resonance imaging (MRI). Objective response rate: complete response (CR-disappearance of all lesions)+ partial response (PR-30% decrease in lesion diameter), Progressive Disease (PD-20% increase in lesion diameter), stable disease (SD-neither shrinkage nor increase of lesions)., Until Day 30 or every 3 months during Follow-up period for patients who complete study without PD.|Duration of Response., As measured by RECIST criteria and defined as the time from the first documented CR or PR until disease progression or death from any cause., From first documented CR or PR until disease progression or death.|Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs), From start of study drug administration up to 30 days after the last dose of study drug (approximately up to 42 months)",,Eisai Inc.,Eisai Limited,FEMALE,"ADULT, OLDER_ADULT",PHASE3,762,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,E7389-G000-305|2006-001949-34,2006-11,2009-05,2013-06,2006-10-17,2012-01-30,2020-01-07,"US Oncology St. Vincent's Hospital - Bruno Cancer Center, Birmingham, Alabama, United States|Bellflower Satellite, Bellflower, California, United States|Research Center, Gilroy, California, 95020, United States|US Oncology, Denver, Colorado, United States|Florida Cancer Research Institute, Davie, Florida, United States|Innovative Medical Research of South Florida, Inc., Miami, Florida, 33179, United States|Peachtree Hematology/Oncology Consultants, PC, Atlanta, Georgia, United States|US Oncology, Niles, Illinois, United States|US Oncology, Indianapolis, Indiana, United States|University of Iowa Hospital and Clinic, Iowa City, Iowa, United States|Hematology Oncology Clinic, Baton Rouge, Louisiana, United States|Oncology Care Associates, P.L.L.C., Saint Joseph, Michigan, United States|US Oncology, Columbia, Missouri, United States|Montana Cancer Specialists, Missoula, Montana, 59820, United States|US Oncology, Las Vegas, Nevada, United States|US Oncology, Albany, New York, United States|North Shore Hematology/Oncology Associates, East Setauket, New York, United States|Weill Cornell Breast Cancer Center, New York, New York, United States|Carolina Hematology Oncology Associates, Charlotte, North Carolina, United States|US Oncology, Raleigh, North Carolina, United States|US Oncology, Eugene, Oregon, United States|St. Vincent Medical Center, Portland, Oregon, United States|US Oncology, Bedford, Texas, United States|US Oncology, Dallas, Texas, United States|US Oncology, Houston, Texas, United States|US Oncology, McAllen, Texas, United States|US Oncology, Midland, Texas, United States|US Oncology, Tyler, Texas, United States|US Oncology, Spokane, Washington, United States|Northwest Medical Specialists, Tacoma, Washington, 98401, United States|US Oncology, Vancouver, Washington, United States|US Oncology, Yakima, Washington, United States|Instituto Oncologico ""Las Heras"", Bahia Blanca, Buenos Aires, B8000ILF, Argentina|Hospital Britanico, C.a.b.a, Buenos Aires, C1280AEB, Argentina|Instituto FIDES especialidades Medicas, La Plata, Buenos Aires, 1900, Argentina|Breast Clinica de la Mama, La Plata, Buenos Aires, Argentina|CER Instituto Medico, Quilmes Oeste, Buenos Aires, Argentina|CITEM, Quilmes, Buenos Aires, Argentina|Instituto CAICI, Rosario, Pcia. Santa Fe, S2000PBJ, Argentina|Centro Medico San Roque, Tucuman, San Miguel De Tucuman, Argentina|Hosptial Interzonal General de Mar del Plata, Buenos Aires, 7600, Argentina|Clinica Universitaria Privada Reina Fabiola, Cordoba, Argentina|Sanatorio Frances, Cordoba, Argentina|Instituto de Oncologia y Especialidades Medicas, Rosario Santa Fe, 2000, Argentina|Clinica Especializada ISIS, Santa Fe, S3000FFU, Argentina|The Queen Elizabeth Hospital, Southport, Queensland, 4215, Australia|Servicio De Oncologia, Woodville South, South Australia, 5011, Australia|Maroondah Breast Clinic, Melbourne, 3135, Australia|Mater Medical Centre, North Sydney, 2060, Australia|Mount Hospital, Perth, 6000, Australia|Royal Perth Hospital, Department of Medical Oncology, Perth, 6000, Australia|Medizinische Universitatsklinik Graz, Graz Steiermark, 8036, Austria|Salzburger Landeskliniken Universitatsklinik fur Innere medizin III, Salzburg, 5020, Austria|Institut Jules Bordet, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, 1200, Belgium|Centre Hospitalier Notre-Dame - Reine Fabiola, Charleroi, 6000, Belgium|UZ Gent, Gent, B-9000, Belgium|AZ Groeninge, Campus Maria's Voorzienigheid, Kortrijk, 8500, Belgium|Centro Regional Integrado de Oncologia-CRIO, Fortaleza, CE, Brazil|Centro de Pesquisas e Estudios do Centro Goiano, Giana, GO, Brazil|Hospital Erasto Gaertner, Curitiba, PA, Brazil|Instituto Nacional do Cancer-Unidade III (INCA III), Rio De Janiero, RJ, Brazil|CPO-Centro de Pesquisas em Oncologia, Porto Alegre, RS, Brazil|CEPHO-Centro de Estudos e Pesquisa de Hematologia e oncologia, Santo Andre, SP, Brazil|Santo Andre Diagnosticos e Tratamentos, Santo Andre, SP, Brazil|Clinica de Oncologia Medica, Sao Paulo, SP, Brazil|Hospital Amaral Carvalho, Vila Assis, SP, Brazil|The Ottawa Hospital Regional Cancer Center, Ottawa, Ontario, Canada|Sunnybrook Odette Cancer Centre, Toronto, Ontario, M4N 3M5, Canada|McGill University Health Centre, Department of Oncology, Gerald Bronfman Center, Montreal, Quebec, Canada|Clinical Hospital Osijek, Osijek, 31000, Croatia|University Hospital Center Zagreb, Zagreb, 1000, Croatia|University Hospital for Tumors Zagreb, Zagreb, 1000, Croatia|Masaryk Memorial Cancer Institute, Brno, 656 53, Czechia|Hospital Jihlava, Jihlava, 58633, Czechia|General Faculty Hospital Prague, Prague, 128 08, Czechia|Fakultni Thomayerova Nemocnice, Prague, 14059, Czechia|Clinic of Radiotherapy and Oncology, Praha 10, 100 34, Czechia|Ustav radia ni onkologie 1. LF UK a FNB, Praha, 18000, Czechia|Centre Paul Papin, Agners Cedex 01, 46033, France|Hopital Jean Minjoz, Besancon, 25030, France|Polyclinique Boredaux Nord Aquitaine, Bordeaux, 33300, France|Centre Francois Baclesse Caen, Caen Cedex 05, 14076, France|Centre Jean Perrin - CRLC, Clermont-Ferrand Cedex 01, 63011, France|Centre Georges-Francois Lecierc, Dijon Cedex, 21079, France|Hopital Edourad Herriot, Lyon, 69008, France|Institut Curie, Paris, 75005, France|Clinique Armoricaine de Radiologie, Saint Brieuc Cedex, 22015, France|Hopital Bretonneau, Tours Cedex, 37044, France|Semmelweis Medical University, III. Dep. of Internal Med., Budapest, 1125, Hungary|Debrecen Medical University, Department of Oncology, Debrecen, 4012, Hungary|University of Pecs, Pecs, 7200, Hungary|Markusovszky Teaching Hospital, Dept. of Oncoradiology, Sec. Med. Oncology, Szombathely, 9700, Hungary|Azienda Ospedaliera Careggi, Firenze (FI), 50139, Italy|Ospedale San Martino, Genova, 16132, Italy|Ospedale ""Vito Fazzi"" - Lecce, Lecce (LE), 73100, Italy|Istituto Scientifico San Raffaele, Milano, 20132, Italy|Ospedale San Filippo Neri, Roma, 00135, Italy|Istituto Clinico Humanitas, Rozzano, 20089, Italy|UO di Oncologia, Sora, 03039, Italy|Akademickie Centrum Kliniczne Szpital Akademii Medycznej w, Gdansk, 80952, Poland|Szpital Morski im PCK w Gdyni Gdynskie Centrum Onkologii, Gdynia, 81519, Poland|Centrum Onkologii Instytut M. Sklodowskiej Curie w Warszawie Oddzial Gilwice, Gilwice, 44101, Poland|Centrum Onkologii Instytut M Sklodowskiej Curie, Oddzial w Krakowie, Krakow, 31-115, Poland|Szpital Kiniczny Przemienienia Panskiego Uniwersyteu Medycznego im Karola Marcinkowskiego w Poznaniu, Poznan, 61878, Poland|Zachodniopomorski e Centrum, Szczecin, 71-730, Poland|Centrum Onkologii Instytut im M. Sklodowskiej Curie w Warszawie, Warszawa, 02781, Poland|Republic Clinical Oncology Dispensary, Izhervsk Udmurtia, 426009, Russian Federation|Kazan State Medical University, Kazan, 420012, Russian Federation|Krasnodar Territory Clinical Oncology Center, Krasnodar, 350040, Russian Federation|Burdenko Main Military Hospital, Moscow, 105229, Russian Federation|Nizhniy Novgorod City Oncology Center, Nizhny Novgorod, 603081, Russian Federation|City Clinical Hospital #1, Novosibirisk, 630047, Russian Federation|Republican Oncology Center, Petrozavodsk, 185007, Russian Federation|State Institution of Healthcare Stavropol Region clinical Oncology dispensary, Pyatigorsk, Russian Federation|St Petersburg City Oncology Center, St Petersburg, 197022, Russian Federation|Pavlov Medical University, St. Petersburg, 190722, Russian Federation|NN Petrov Research Institute of Oncology, St. Petersburg, 197758, Russian Federation|Tomsk Regional Oncology Dispensary, Tomsk, 634050, Russian Federation|GUZ YO Regional Clinical Oncology Hospital, Yaroslavl, 150054, Russian Federation|Panorama Medical Centre, Panorama, Cape Town, 7500, South Africa|Eastern Cape Oncology Centre, GVI, St Georges Hospital, Port Elizabeth, Eastern Cape, 6001, South Africa|Sandton Oncology Centre, Johannesburg, 2057, South Africa|Pretoria Academic Hospital, Pretoria, 0001, South Africa|Hospital Vall d Hebron, Barcelona, 08035, Spain|Hospital Mutua de Terrassa, Barcelona, E-08221, Spain|Hospital Universitario de Girona Dr. Josep Trueta, Gerona, 17007, Spain|Complejo Hospitalario de Jaen, Jaen, E-23007, Spain|Hospital Unversitatio de Salamanca, Salamanca, E37007, Spain|Hospital Universitario de Canarias, Santa Cruz de Tenerife, E-38320, Spain|Hospital General Virgen del Rocio, Sevilla, E-41013, Spain|Hospital Clinico de Zaragoza, Zanagoza, 50009, Spain|Kantonsspital Aarau, Aarau, 5001, Switzerland|Inselspital Bern, Bern Bern, 3010, Switzerland|Kantonsspital Oncology Haematology, St. Gallen, CH9007, Switzerland|Spital Thun-Simmental AG, Thun, 3600, Switzerland|Kantonsspital Winterhur, Winterhur, CH-8401, Switzerland",
